Rimonabant Abolishes Sensitivity to Workload Changes in a Progressive Ratio Procedure

Overview

Journal Pharmacol Biochem Behav

Publisher Elsevier

Specialties Biochemistry
Pharmacology
Psychology
Social Sciences

Date 2012 Mar 20

PMID 22425597

Citations 2

Authors

Julie A Marusich

Jenny L Wiley

Affiliations

Soon will be listed here.

Abstract

Despite its propensity to increase motivation for food consumption, marijuana use in humans has been associated with "amotivational syndrome." This "amotivational syndrome" can be characterized by a reduction in response persistence in tasks requiring sustained, but not maximal, effort. To examine this hypothesis, dose-effect functions for THC (0.03-10 mg/kg) and rimonabant (0.1-10 mg/kg) were first determined under a time-constrained PR 5 schedule. During the second phase of the study, doses of THC and rimonabant that did not affect the responses/total reinforced responses were chosen for further evaluation in a series of PR schedules with step sizes of PR 3, PR 5, PR 10, and PR exponential. THC and rimonabant produced decreases in responses per reinforcer, and response rate when behavior was maintained on a PR 5. Rimonabant also decreased session length. During the PR step size manipulation phase, rimonabant decreased responses/total reinforced responses, response rate, and session length, whereas THC only decreased response rate. These results are consistent with previous literature demonstrating that rimonabant decreases motivation for food both in cases where it is earned, as well as under free-feeding conditions, whereas the effects of cannabinoid agonists such as THC on responding for food exhibit greater dependence upon motivational and non-motivational factors, including workload and duration of the task.

Citing Articles

Differential disruption of response alternation by precipitated Δ-THC withdrawal and subsequent Δ-THC abstinence in mice.

Eckard M, Kinsey S Pharmacol Biochem Behav. 2024; 236:173718.

PMID: 38272272 PMC: 10955601. DOI: 10.1016/j.pbb.2024.173718.

Long-term effects of THC exposure on reward learning and motivated behavior in adolescent and adult male rats.

Halbout B, Hutson C, Hua L, Inshishian V, Mahler S, Ostlund S Psychopharmacology (Berl). 2023; 240(5):1151-1167.

PMID: 36933028 PMC: 10102061. DOI: 10.1007/s00213-023-06352-4.

References

Solinas M, Goldberg S . Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology. 2005; 30(11):2035-45. DOI: 10.1038/sj.npp.1300720. View

Foltin R, FISCHMAN M, Brady J, Kelly T, Bernstein D, Nellis M . Motivational effects of smoked marijuana: behavioral contingencies and high-probability recreational activities. Pharmacol Biochem Behav. 1989; 34(4):871-7. DOI: 10.1016/0091-3057(89)90287-6. View

Chaperon F, Thiebot M . Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol. 2000; 13(3):243-81. DOI: 10.1615/critrevneurobiol.v13.i3.20. View

Wiley J, Razdan R, Martin B . Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Life Sci. 2006; 80(1):24-35. DOI: 10.1016/j.lfs.2006.08.017. View

Ward S, Lefever T, Jackson C, Tallarida R, Walker E . Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharmacol Exp Ther. 2008; 325(2):567-76. DOI: 10.1124/jpet.107.131771. View

Williams C, Rogers P, Kirkham T . Hyperphagia in pre-fed rats following oral delta9-THC. Physiol Behav. 1998; 65(2):343-6. DOI: 10.1016/s0031-9384(98)00170-x. View

Wiley J, Smith F, Razdan R, Dewey W . Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. Eur J Pharmacol. 2005; 510(1-2):59-68. DOI: 10.1016/j.ejphar.2005.01.006. View

De Vry J, Schreiber R, Eckel G, Jentzsch K . Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. Eur J Pharmacol. 2004; 483(1):55-63. DOI: 10.1016/j.ejphar.2003.10.012. View

Riedel G, Fadda P, McKillop-Smith S, Pertwee R, Platt B, Robinson L . Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Br J Pharmacol. 2009; 156(7):1154-66. PMC: 2697695. DOI: 10.1111/j.1476-5381.2008.00107.x. View

10.

Wiley J, Burston J, Leggett D, Alekseeva O, Razdan R, Mahadevan A . CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol. 2005; 145(3):293-300. PMC: 1576140. DOI: 10.1038/sj.bjp.0706157. View

11.

Foltin R, FISCHMAN M, Byrne M . Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite. 1988; 11(1):1-14. DOI: 10.1016/s0195-6663(88)80017-5. View

12.

Carriero D, Aberman J, Lin S, Hill A, Makriyannis A, Salamone J . A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing. Psychopharmacology (Berl). 1998; 137(2):147-56. DOI: 10.1007/s002130050604. View

13.

Bickel W, Marsch L, Carroll M . Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal. Psychopharmacology (Berl). 2001; 153(1):44-56. DOI: 10.1007/s002130000589. View

14.

Mobini S, Chiang T, Ho M, Bradshaw C, Szabadi E . Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology (Berl). 2000; 152(1):47-54. DOI: 10.1007/s002130000486. View

15.

Wiley J, Compton A . Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine. Psychopharmacology (Berl). 2004; 177(1-2):170-7. PMC: 2637914. DOI: 10.1007/s00213-004-1936-1. View

16.

Richardson N, Roberts D . Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci. 1991; 49(11):833-40. DOI: 10.1016/0024-3205(91)90248-a. View

17.

Foltin R, FISCHMAN M, Brady J, Bernstein D, Capriotti R, Nellis M . Motivational effects of smoked marijuana: behavioral contingencies and low-probability activities. J Exp Anal Behav. 1990; 53(1):5-19. PMC: 1323020. DOI: 10.1901/jeab.1990.53-5. View

18.

Gelfand E, Cannon C . Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors. Expert Opin Investig Drugs. 2006; 15(3):307-15. DOI: 10.1517/13543784.15.3.307. View

19.

Cherek D, Lane S, Dougherty D . Possible amotivational effects following marijuana smoking under laboratory conditions. Exp Clin Psychopharmacol. 2002; 10(1):26-38. DOI: 10.1037//1064-1297.10.1.26. View

20.

Hao S, Avraham Y, Mechoulam R, Berry E . Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol. 2000; 392(3):147-56. DOI: 10.1016/s0014-2999(00)00059-5. View